THE NEW ENGLAND JOURNAL OF MEDICINE
NEJM
December 28, 2023
Vol. 389 No. 26

目次一部抜粋
ORIGINAL ARTICLES
Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants
Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia

REVIEW ARTICLE
Wearable Digital Health Technologies in Medicine: Wearable Technology in Clinical Practice for Depressive Disorder

EDITORIALS
Extending Dual Antiplatelet Therapy for TIA or Stroke
RSV Prevention — Breakthroughs and Challenges
Sparsentan — Another Arrow in the Quiver for Treatment of FSGS?
Optimizing Blood Transfusion in Patients with Acute Myocardial Infarction

CORRESPONDENCE
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation
Artemisinin-Resistant HRP2-Negative Malaria in Eritrea
Ceftobiprole for Staphylococcus aureus Bacteremia

複数冊同時購入・同梱可能の際はお値引きします。
#kurashina_NEJM